Harch Hyperbaric Research Foundation   Report issue

Foundation Phase 1
Founded: Marrero LA United States

Organization Overview

First Clinical Trial
2002
NCT00592891
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

oxygen (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 1)

Brain Injuries, Traumatic (Phase 1)

Brain Injury, Chronic (Phase 1)

Wounds and Injuries (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 1